CBR Pharma Insights Market Research Reports

Title published price

Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies

By CBR Pharma Insights

Summary Latest report, Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies, provides an in-depth assessment of the current trends in the global cosmeceu ...

01-Feb-2018 $2995

Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis

By CBR Pharma Insights

Summary “Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis” dis ...

01-Feb-2018 $2995

Nutraceuticals: New Applications for Probiotics, Genetic Modification and Diet as Products Make Gains in Rx Territory

By CBR Pharma Insights

Summary The nutraceuticals market is growing and diversifying rapidly. These products are linked by the fact that they are dietary products that have some degree of either purported or clinically evidenced medical benefit. ...

01-Dec-2017 $2995

Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape

By CBR Pharma Insights

Antibodies, otherwise known as immunoglobulins (Ig), are large, Y-shaped glycoproteins produced by immune cells in response to pathogens such as bacteria and viruses. They consist of two large heavy polypeptide chains and two smaller light polypep ...

01-Nov-2017 $2995

A Global Hyperhidrosis Market Landscape Assessment: Trends, Forecasts and Opportunities in a Growing Market

By CBR Pharma Insights

Hyperhidrosis is a chronic disorder of excessive sweating beyond thermoregulatory needs and environmental conditions. It commonly arises in childhood and adolescence, and can affect patients for many years. Most cases of hyperhidrosis involve area ...

19-Oct-2017 $2995

Current and Future Trends in Rx-to-OTC Switching with Insight from Key Industry Opinion Leaders

By CBR Pharma Insights

Summary Rx-to-OTC switching is the process of transferring Rx pharmaceuticals to non-prescription OTC status for the same dosage form, population, and route of administration. OTC drugs are defined as those that are safe a ...

05-Oct-2017 $2995

Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics

By CBR Pharma Insights

Summary Pharmaceutical market is continuing to see global growth, whereas pharmaceutical and biotechnology companies are facing challenges due to disruptive events in the healthcare market such as increasing costs of produ ...

01-Jul-2017 $2995

Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017

By CBR Pharma Insights

Summary mHealth is often regarded as a branch of eHealth, which has been defined by the European Commission as “The use of modern information and communication technologies to meet needs of citizens, patients, health ...

01-Jun-2017 $2995

Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline

By CBR Pharma Insights

Summary Innovation is a crucial element of the pharmaceutical industry. The market is highly research-intensive, being deeply reliant on a high level of R&D investment and a strong product pipeline to maintain growth a ...

01-May-2017 $2995

Pharmaceutical Lifecycle Management Strategies in 2017

By CBR Pharma Insights

Pharmaceutical lifecycle management (LCM) is the process of managing the entire lifecycle of a product including its research, design and manufacture, service and disposal. LCM is a well-established tool to maximize sales throughout the product li ...

01-Apr-2017 $2995

Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design

By CBR Pharma Insights

Summary Government support for biosimilars is increasing in key geographical markets, given the cost saving opportunities that these products represent for national healthcare budgets. A biosimilar is a bio-therapeutic tha ...

01-Mar-2017 $2995

Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing

By CBR Pharma Insights

Multichannel marketing (MCM) refers to the integration of various marketing channels into an overall synergetic strategy. Utilization of information from all the channels in a feedback loop is termed closed-loop marketing (CLM). While they require ...

24-Feb-2017 $2995

Big Data: Embracing Data to Transform Healthcare and Pharma Commercial Strategy - Featuring Expert Panel Views from Industry Survey 2016

By CBR Pharma Insights

Data generation is growing at an exponential rate, so much so that 90% of the data in the world today was created in the last two years (IBM, 2016a). Big Data refers to any data set that is too large to store, process or analyze using traditional ...

05-Dec-2016 $2995

Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period

By CBR Pharma Insights

Drug delivery technologies are engineered technologies that deliver drugs to achieve a therapeutic effect. Advances in these technologies usually aim to increase the efficacy of the drug, improve drug absorption and decrease side effects. The glob ...

01-Nov-2016 $2995

Strategic Trends in Private Equity and Venture Capital Funding for Healthcare

By CBR Pharma Insights

Private Equity is a term used to refer to money invested in private companies, and those companies become private through investment. However, in the financial industry the term is used to refer to firms that buy companies through leveraged buyout ...

01-Nov-2016 $2995

The Future of Generic Drugs and Strategies for Commercial Success

By CBR Pharma Insights

Generic drugs are identical or bioequivalent to branded drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Although generic drugs are chemically identical to their branded counte ...

01-Sep-2016 $2995

Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape

By CBR Pharma Insights

GBI Research’s latest report, ""Stem Cell Therapies Global Trends in the Competitive, Technological and R&D Landscape"" provides an in-depth assessment of the current trends in the global stem cell therapy sector with a particular focus ...

01-Jul-2016 $2995

Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs

By CBR Pharma Insights

GBI Research's latest report, ""Human Drugs For Veterinary Use Current Trends and Future Commercial Prospects for Crossover Drugs"", discusses global commercial trends and prospects for human medicines applied in the veterinary setting, also calle ...

01-Jun-2016 $2995

Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline

By CBR Pharma Insights

GBI Research’s latest report, ""Innovation Tracking Factbook 2016An Assessment of the Pharmaceutical Pipeline"" is a comprehensive, granular analysis of the 20,756 products currently in the pharmaceutical industry pipeline, from the Discover ...

01-Jun-2016 $2995

Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape

By CBR Pharma Insights

GBI Research's latest report, "Substance Abuse Deterrents and Treatments An Assessment of the Technological, Competitive and R&D Landscape", discusses global trends in the substance abuse deterrents and addiction treatments market including th ...

16-Mar-2016 $2995